Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.0%

1 terminated/withdrawn out of 98 trials

Success Rate

96.0%

+9.5% vs industry average

Late-Stage Pipeline

13%

13 trials in Phase 3/4

Results Transparency

0%

0 of 24 completed trials have results

Key Signals

18 recruiting

Enrollment Performance

Analytics

N/A
36(54.5%)
Phase 2
10(15.2%)
Phase 4
8(12.1%)
Phase 1
5(7.6%)
Phase 3
5(7.6%)
Early Phase 1
2(3.0%)
66Total
N/A(36)
Phase 2(10)
Phase 4(8)
Phase 1(5)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (98)

Showing 20 of 98 trials
NCT04962958Phase 2Completed

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

Role: collaborator

NCT06968806Phase 3Recruiting

Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection

Role: collaborator

NCT07361783Not ApplicableRecruiting

Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI-2 Trial

Role: collaborator

NCT07645209Active Not Recruiting

A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions

Role: collaborator

NCT07620626Recruiting

Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment

Role: collaborator

NCT07622446Not ApplicableActive Not Recruiting

Evaluate the Effectiveness and Safety of the OmniHeart 4.0 Percutaneous Ventricular Assist Device in Providing Hemodynamic Support for Patients Undergoing High-risk Percutaneous Coronary Intervention (PCI).

Role: collaborator

NCT04053205Phase 1Completed

A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer

Role: collaborator

NCT07332858Phase 1Recruiting

First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion

Role: collaborator

NCT04968028Not ApplicableActive Not Recruiting

Multi-centre Study to Evaluate ACAF Versus Laminoplasty in Treating Cervical Ossification of the Posterior Longitudinal Ligament

Role: collaborator

NCT06274411Not ApplicableRecruiting

Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention

Role: collaborator

NCT03385902Not ApplicableCompleted

Assessment of Dialysis Initiation by a Fuzzy Mathematics Equation

Role: collaborator

NCT06284642Phase 4Recruiting

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Role: collaborator

NCT03115931Completed

The Effect of Preoperative Nutritional Assessment and Nutritional Support on Clinical Outcomes

Role: collaborator

NCT06741839Not ApplicableRecruiting

Confocal Laser Endomicroscopy Guided Medical Thoracoscopy for the Diagnosis of Pleural Disease

Role: collaborator

NCT07438119Phase 4Not Yet Recruiting

Efficacy Comparison of DExamethasone Intravitreal Implant Combined With Aflibercept Versus Aflibercept Monotherapy in Treatment-naïve Inflammatory Diabetic Macular Edema Patients

Role: collaborator

NCT07402525Not ApplicableRecruiting

Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial

Role: collaborator

NCT07130955Not ApplicableEnrolling By Invitation

A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease

Role: collaborator

NCT03649503Recruiting

The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China

Role: collaborator

NCT04555226Not ApplicableRecruiting

The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)

Role: collaborator

NCT07128251Phase 2Not Yet Recruiting

A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)

Role: collaborator